Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

[1]  Anssi Auvinen,et al.  Loss of SUFU function in familial multiple meningioma. , 2012, American journal of human genetics.

[2]  Matthew J. Betts,et al.  Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.

[3]  Kristian Helin,et al.  Molecular mechanisms and potential functions of histone demethylases , 2012, Nature Reviews Molecular Cell Biology.

[4]  W. Vandertop,et al.  Impaired survival and long-term neurological problems in benign meningioma. , 2012, Neuro-oncology.

[5]  Tadashi Kaname,et al.  New from NPG , 2012, Nature Medicine.

[6]  T. Fennell,et al.  Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.

[7]  Razelle Kurzrock,et al.  PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Eric S. Lander,et al.  Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.

[9]  David T. W. Jones,et al.  Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.

[10]  Mark D. Johnson,et al.  Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. , 2012, Neoplasia.

[11]  R. Drapkin,et al.  Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. , 2011, Gynecologic oncology.

[12]  Takashi Igarashi,et al.  Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma , 2011, Cancer science.

[13]  Kristian Cibulskis,et al.  Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion , 2011, Nature Genetics.

[14]  I. R. Ruiz,et al.  PTCH1 gene mutations in exon 17 and loss of heterozygosity on D9S180 microsatellite in sporadic and inherited human basal cell carcinomas , 2011, International journal of dermatology.

[15]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[16]  I. Yang,et al.  The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. , 2011, Neurosurgical focus.

[17]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[18]  Trevor J Pugh,et al.  Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.

[19]  Arie Perry,et al.  Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups , 2011, Acta Neuropathologica.

[20]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[21]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[22]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[23]  R. Beroukhim,et al.  Medical therapies for meningiomas , 2010, Journal of Neuro-Oncology.

[24]  Arie Perry,et al.  Pathological classification and molecular genetics of meningiomas , 2010, Journal of Neuro-Oncology.

[25]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[26]  P. Park,et al.  Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status , 2010, Clinical Cancer Research.

[27]  I. Salmon,et al.  Gene Expression Profiling of the Hedgehog Signaling Pathway in Human Meningiomas , 2010, Molecular medicine.

[28]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[29]  Raoul Tibes,et al.  Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. , 2009, The New England journal of medicine.

[30]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[31]  A. Jouvet,et al.  WHO grade II and III meningiomas: a study of prognostic factors , 2009, Journal of Neuro-Oncology.

[32]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[33]  Derek Y. Chiang,et al.  High-resolution mapping of copy-number alterations with massively parallel sequencing , 2009, Nature Methods.

[34]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[35]  A. Marchetti,et al.  AKT1E17K in human solid tumours , 2008, Oncogene.

[36]  Levi Garraway,et al.  SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines , 2008, Nucleic acids research.

[37]  C. Bolger,et al.  Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis , 2008, Journal of Medical Genetics.

[38]  N. Krayenbühl,et al.  DE NOVO VERSUS TRANSFORMED ATYPICAL AND ANAPLASTIC MENINGIOMAS: COMPARISONS OF CLINICAL COURSE, CYTOGENETICS, CYTOKINETICS, AND OUTCOME , 2007, Neurosurgery.

[39]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[40]  J. Rahnenführer,et al.  Hyperdiploidy defines a distinct cytogenetic entity of meningiomas , 2007, Journal of Neuro-Oncology.

[41]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[42]  C. Emerson,et al.  Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Yiping Shen,et al.  Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma. , 2005, Cancer genetics and cytogenetics.

[44]  J. Ptak,et al.  High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.

[45]  A. Deimling,et al.  INI1 mutations in meningiomas at a potential hotspot in exon 9 , 2001, British Journal of Cancer.

[46]  B. Scheithauer,et al.  "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. , 1999, Cancer.

[47]  M. Wolter,et al.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. , 1998, Cancer research.

[48]  C. Lindquist,et al.  Recurrence of cranial base meningiomas. , 1996, Neurosurgery.

[49]  D. Lenartz,et al.  Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. , 1995, The American journal of pathology.

[50]  D. Stevanović.  Nevoid basal cell carcinoma syndrome. , 1967, Archives of dermatology.